Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: Results of a 16-year prospective study

Katherine E. McArthur, Charles T. Richardson, Cora C. Barnett, Nahid Eshaghi, Michael J. Smerud, Robert N. McClelland, Mark Feldman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: Pharmacological control of gastric acid hypersecretion in the Zollinger-Ellison syndrome has steadily improved, but medical treatment does not address the underlying tumor. The objective of this study was to evaluate the long-term effectiveness of a surgical approach to both tumor and acid hypersecretion in 22 patients with the Zollinger-Ellison syndrome. Methods: Patients underwent laparotomy to resect tumors, combined with vagotomy to reduce acid secretion, followed by postoperative antisecretory therapy, if necessary. Results: No surgical mortality or serious morbidity occurred. Tumor was found at laparotomy in nine patients (41%) and during long-term follow-up in an additional two patients (9%). Ten-year survival is 81%, with a long-term cure rate of at least 14%. Most patients (86%) have had long- term inhibition of acid secretion. Eight patients have discontinued regular use of acid-inhibiting medications. Patients requiring medication need less of it, and they have an improved acid inhibitory response to medication for up to 16 yr after surgery. Conclusion: Cure of the Zollinger-Ellison syndrome is possible in a minority of patients. Acid secretion can be safely reduced in almost all patients with laparotomy/vagotomy, usually allowing discontinuation, or reduced dose, of acid-inhibiting drugs. Long-term survival and quality of life are generally excellent.

Original languageEnglish (US)
Pages (from-to)1104-1111
Number of pages8
JournalAmerican Journal of Gastroenterology
Volume91
Issue number6
StatePublished - Jun 1 1996

Fingerprint

Proximal Gastric Vagotomy
Zollinger-Ellison Syndrome
Laparotomy
Prospective Studies
Acids
Vagotomy
Neoplasms
Survival
Gastric Acid
Quality of Life
Pharmacology
Morbidity

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

McArthur, K. E., Richardson, C. T., Barnett, C. C., Eshaghi, N., Smerud, M. J., McClelland, R. N., & Feldman, M. (1996). Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: Results of a 16-year prospective study. American Journal of Gastroenterology, 91(6), 1104-1111.

Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome : Results of a 16-year prospective study. / McArthur, Katherine E.; Richardson, Charles T.; Barnett, Cora C.; Eshaghi, Nahid; Smerud, Michael J.; McClelland, Robert N.; Feldman, Mark.

In: American Journal of Gastroenterology, Vol. 91, No. 6, 01.06.1996, p. 1104-1111.

Research output: Contribution to journalArticle

McArthur, KE, Richardson, CT, Barnett, CC, Eshaghi, N, Smerud, MJ, McClelland, RN & Feldman, M 1996, 'Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: Results of a 16-year prospective study', American Journal of Gastroenterology, vol. 91, no. 6, pp. 1104-1111.
McArthur, Katherine E. ; Richardson, Charles T. ; Barnett, Cora C. ; Eshaghi, Nahid ; Smerud, Michael J. ; McClelland, Robert N. ; Feldman, Mark. / Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome : Results of a 16-year prospective study. In: American Journal of Gastroenterology. 1996 ; Vol. 91, No. 6. pp. 1104-1111.
@article{c97f914229864f18b3b498a85cdf2682,
title = "Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome: Results of a 16-year prospective study",
abstract = "Objective: Pharmacological control of gastric acid hypersecretion in the Zollinger-Ellison syndrome has steadily improved, but medical treatment does not address the underlying tumor. The objective of this study was to evaluate the long-term effectiveness of a surgical approach to both tumor and acid hypersecretion in 22 patients with the Zollinger-Ellison syndrome. Methods: Patients underwent laparotomy to resect tumors, combined with vagotomy to reduce acid secretion, followed by postoperative antisecretory therapy, if necessary. Results: No surgical mortality or serious morbidity occurred. Tumor was found at laparotomy in nine patients (41{\%}) and during long-term follow-up in an additional two patients (9{\%}). Ten-year survival is 81{\%}, with a long-term cure rate of at least 14{\%}. Most patients (86{\%}) have had long- term inhibition of acid secretion. Eight patients have discontinued regular use of acid-inhibiting medications. Patients requiring medication need less of it, and they have an improved acid inhibitory response to medication for up to 16 yr after surgery. Conclusion: Cure of the Zollinger-Ellison syndrome is possible in a minority of patients. Acid secretion can be safely reduced in almost all patients with laparotomy/vagotomy, usually allowing discontinuation, or reduced dose, of acid-inhibiting drugs. Long-term survival and quality of life are generally excellent.",
author = "McArthur, {Katherine E.} and Richardson, {Charles T.} and Barnett, {Cora C.} and Nahid Eshaghi and Smerud, {Michael J.} and McClelland, {Robert N.} and Mark Feldman",
year = "1996",
month = "6",
day = "1",
language = "English (US)",
volume = "91",
pages = "1104--1111",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Laparotomy and proximal gastric vagotomy in Zollinger-Ellison syndrome

T2 - Results of a 16-year prospective study

AU - McArthur, Katherine E.

AU - Richardson, Charles T.

AU - Barnett, Cora C.

AU - Eshaghi, Nahid

AU - Smerud, Michael J.

AU - McClelland, Robert N.

AU - Feldman, Mark

PY - 1996/6/1

Y1 - 1996/6/1

N2 - Objective: Pharmacological control of gastric acid hypersecretion in the Zollinger-Ellison syndrome has steadily improved, but medical treatment does not address the underlying tumor. The objective of this study was to evaluate the long-term effectiveness of a surgical approach to both tumor and acid hypersecretion in 22 patients with the Zollinger-Ellison syndrome. Methods: Patients underwent laparotomy to resect tumors, combined with vagotomy to reduce acid secretion, followed by postoperative antisecretory therapy, if necessary. Results: No surgical mortality or serious morbidity occurred. Tumor was found at laparotomy in nine patients (41%) and during long-term follow-up in an additional two patients (9%). Ten-year survival is 81%, with a long-term cure rate of at least 14%. Most patients (86%) have had long- term inhibition of acid secretion. Eight patients have discontinued regular use of acid-inhibiting medications. Patients requiring medication need less of it, and they have an improved acid inhibitory response to medication for up to 16 yr after surgery. Conclusion: Cure of the Zollinger-Ellison syndrome is possible in a minority of patients. Acid secretion can be safely reduced in almost all patients with laparotomy/vagotomy, usually allowing discontinuation, or reduced dose, of acid-inhibiting drugs. Long-term survival and quality of life are generally excellent.

AB - Objective: Pharmacological control of gastric acid hypersecretion in the Zollinger-Ellison syndrome has steadily improved, but medical treatment does not address the underlying tumor. The objective of this study was to evaluate the long-term effectiveness of a surgical approach to both tumor and acid hypersecretion in 22 patients with the Zollinger-Ellison syndrome. Methods: Patients underwent laparotomy to resect tumors, combined with vagotomy to reduce acid secretion, followed by postoperative antisecretory therapy, if necessary. Results: No surgical mortality or serious morbidity occurred. Tumor was found at laparotomy in nine patients (41%) and during long-term follow-up in an additional two patients (9%). Ten-year survival is 81%, with a long-term cure rate of at least 14%. Most patients (86%) have had long- term inhibition of acid secretion. Eight patients have discontinued regular use of acid-inhibiting medications. Patients requiring medication need less of it, and they have an improved acid inhibitory response to medication for up to 16 yr after surgery. Conclusion: Cure of the Zollinger-Ellison syndrome is possible in a minority of patients. Acid secretion can be safely reduced in almost all patients with laparotomy/vagotomy, usually allowing discontinuation, or reduced dose, of acid-inhibiting drugs. Long-term survival and quality of life are generally excellent.

UR - http://www.scopus.com/inward/record.url?scp=0029934928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029934928&partnerID=8YFLogxK

M3 - Article

C2 - 8651153

AN - SCOPUS:0029934928

VL - 91

SP - 1104

EP - 1111

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 6

ER -